Zobrazeno 1 - 10
of 44
pro vyhledávání: '"L N, Shilova"'
Autor:
G. Ya. Osmanova, V. A. Aleksandrov, A. V. Aleksandrov, L. N. Shilova, E. G. Cherkesova, N. V. Aleksandrova, I. A. Zborovskaya
Publikováno v:
Медицинская иммунология, Vol 26, Iss 2, Pp 393-400 (2024)
Low-energy fractures in rheumatoid arthritis (RA) are more common in patients with high activity and long duration of disease, and with high titers of anti-citrullinated antibodies (ACPA). Increased expression of angiopoietin-like protein type 4 (ANG
Externí odkaz:
https://doaj.org/article/07d775b26928444f94c57ee018874d37
Autor:
A. V. Aleksandrov, L. N. Shilova, V. A. Aleksandrov, M. V. Levkina, O. V. Paramonova, N. V. Aleksandrova, I. A. Zborovskaya
Publikováno v:
Медицинская иммунология, Vol 25, Iss 4, Pp 927-932 (2023)
The study aimed to evaluate the association between cyclic citrullinated peptide antibody seropositivity and chronic Helicobacter pylori (H. pylori) infection in patients with rheumatoid arthritis (RA). We examined 92 women with moderate RA activity.
Externí odkaz:
https://doaj.org/article/ce491594be9a49a79308f5886d195a53
Autor:
V. I. Mazurov, A. M. Lila, M. A. Korolev, A. M. Prystrom, A. V. Kundzer, N. F. Soroka, A. A. Kastanayan, T. V. Povarova, T. V. Plaksina, O. V. Antipova, D. G. Krechikova, S. A. Smakotina, O. A. Tciupa, E. V. Puntus, T. A. Raskina, L. N. Shilova, T. V. Kropotina, O. B. Nesmeyanova, T. A. Popova, I. B. Vinogradova, E. A. Dokukina, A. V. Plotnikova, P. S. Pukhtinskaia, A. V. Zinkina-Orikhan, Yu. N. Linkova, A. V. Eremeeva, A. A. Lutckii, E. L. Nasonov
Publikováno v:
Научно-практическая ревматология, Vol 61, Iss 1, Pp 87-99 (2023)
Background. Previously, 24-week results of phase III double-blind, placebo-controlled randomized clinical study (SOLAR) of levilimab in subjects with active rheumatoid arthritis (RA) proved a superiority of levilimab over placebo. Here we present 1-y
Externí odkaz:
https://doaj.org/article/4769ca6bff3645e4857fcaa192e698f0
Publikováno v:
Медицинская иммунология, Vol 23, Iss 4, Pp 717-724 (2021)
Rheumatoid arthritis (RA) is a frequent background for the development of renal pathology. Chronic kidney disease (CKD) is determined in more than 30% of patients with RA. Along with inflammation and other factors in the progression of the underlying
Externí odkaz:
https://doaj.org/article/c6fbf28908be406fb8d338cde6fbfd67
Autor:
V. I. Mazurov, M. A. Korolev, A. M. Prystrom, E. V. Kunder, N. F. Soroka, A. A. Kastanayan, T. V. Povarova, T. V. Plaksina, O. V. Antipova, D. G. Kretchikova, S. A. Smakotina, O. A. Tciupa, E. V. Puntus, T. A. Raskina, L. N. Shilova, T. V. Kropotina, O. B. Nesmeyanova, T. A. Popova, I. B. Vinogradova, Yu. N. Linkova, E. A. Dokukina, A. V. Plotnikova, P. S. Pukhtinskaia, A. V. Zinkina-Orikhan, A. V. Eremeeva, A. A. Lutckii
Publikováno v:
Современная ревматология, Vol 15, Iss 4, Pp 13-23 (2021)
Levilimab is anti-interleukin-6 receptor (IL6R) monoclonal antibody. The article presents data obtained during 24 weeks of the SOLAR phase III study.Objective: to confirm efficacy and safety of levilimab in combination with methotrexate (MTX) in pati
Externí odkaz:
https://doaj.org/article/e5807cdebb9f4373ba05f16f3438579e
Publikováno v:
Medical alphabet. :36-39
The clinical picture of the ankylosing spondylitis (AS) is quite diverse. Extra-articular manifestations such as eye involvement (uveitis), damage of the aorta (aortitis), aortic valve insufficiency, inflammatory bowel disease, IgA nephropathy are of
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::41440dfa7348d524c0674c6d0026b3c2
https://doi.org/10.33667/2078-5631-2022-15-36-39
https://doi.org/10.33667/2078-5631-2022-15-36-39
Publikováno v:
Medical alphabet. :53-57
Introduction. Ankylosing spondylitis and Crohn's disease are chronic recurrent autoimmune diseases. In case of a combined course their activity tends to progress, regardless of the phase of the underlying disease.The aim of the study. To analyze the
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::eb2eb013d9a776a9dbfa1c12fa524317
https://doi.org/10.33667/2078-5631-2021-33-53-57
https://doi.org/10.33667/2078-5631-2021-33-53-57
Publikováno v:
Medicinskaâ Immunologiâ, Vol 23, Iss 4, Pp 717-724 (2021)
Rheumatoid arthritis (RA) is a frequent background for the development of renal pathology. Chronic kidney disease (CKD) is determined in more than 30% of patients with RA. Along with inflammation and other factors in the progression of the underlying
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::682e2110e2a17b36d9b174c3c65f4d42
https://www.mimmun.ru/mimmun/article/view/2256
https://www.mimmun.ru/mimmun/article/view/2256
Autor:
S. S. Spitsina, L. N. Shilova
Publikováno v:
Medical alphabet. :35-40
Rheumatoid arthritis is the most common rheumatic disease characterized by damage to the synovium, progressive destruction of cartilage and bone tissue. As a result of the establishment of the biological role of cytokines, it became possible to inter
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::7140078cef31c4d9229c09a036cbb450
https://doi.org/10.33667/2078-5631-2021-16-35-40
https://doi.org/10.33667/2078-5631-2021-16-35-40
Publikováno v:
Medical alphabet. :44-48
The development of renal dysfunction in patients with rheumatoid arthritis (RA) is due to the presence and severity of autoimmune disorders, chronic systemic inflammation, a multiplicity of comorbid conditions, and pharmacotherapy features. The most
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::4b135496b7d398491499619fc01749e5
https://doi.org/10.33667/2078-5631-2020-15-44-48
https://doi.org/10.33667/2078-5631-2020-15-44-48